Advisor(s)
Abstract(s)
Introduction: As the relative burden of community-acquired bacterial pneumonia among HIV-positive patients
increases, adequate prediction of case severity on presentation is crucial. We sought to determine what characteristics
measurable on presentation are predictive of worse outcomes.
Methods: We studied all admissions for community-acquired bacterial pneumonia over 1 year at a tertiary centre.
Patient demographics, comorbidities, HIV-specific markers and CURB-65 scores on Emergency Department presentation
were reviewed. Outcomes of interest included mortality, bacteraemia, intensive care unit admission and orotracheal
intubation.
Results: A total of 396 patients were included, 49 HIV positive and 347 HIV negative. Mean CURB-65 score was 1.3 for
HIV-positive and 2.2 for HIV-negative patients (p<0.0001), its predictive value for mortality being maintained in both
groups (p¼0.03 and p<0.001, respectively). Adjusting for CURB-65 scores, HIV infection by itself was only associated
with bacteraemia (adjusted odds ratio 7.1 CI 95% [2.6–19.5]). Patients with<200 CD4 cells/mL presented similar CURB-
65 adjusted mortality (adjusted odds ratio 1.7 CI 95% [0.2–15.2]), but higher risk of intensive care unit admission
(adjusted odds ratio 5.7 CI 95% [1.5–22.0]) and orotracheal intubation (adjusted odds ratio 9.1 CI 95% [2.2–37.1]),
compared to HIV-negative patients. These two associations were not observed in the>200 CD4 cells/mL subgroup
(adjusted odds ratio 2.2 CI 95% [0.7–7.6] and adjusted odds ratio 0.8 CI 95% [0.1–6.5] respectively). Antiretroviral
therapy and viral load suppression were not associated with different outcomes (p>0.05).
Conclusions: High CURB-65 scores and CD4 counts<200 cells/mL were both associated with worse outcomes.
Severity assessment scales and CD4 counts may both be helpful in predicting severity in HIV-positive patients presenting
with community-acquired bacterial pneumonia.
Description
Keywords
HIV Pneumonia Clinical prediction rule
Citation
International Journal of STD and AIDS, 27, 998-1004. Doi: 10.1177/0956462415605232.
Publisher
SAGE Publications